SPICKSCHEN THORLEF

CIK 00012683742 companiesBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001268374

Recent Transactions

39 trades

Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2021-06-10+42,223→ 42,223 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2020-06-04+40,138→ 40,138 total
Purchase
Clovis Oncology, Inc.
Common Stock
2019-08-16$5.67/sh+8,600→ 58,176 total
Purchase
Clovis Oncology, Inc.
Common Stock
2019-08-14$5.46/sh+9,200→ 49,576 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2019-06-06+28,882→ 28,882 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2019-01-03$3.08/sh+6,896→ 14,514 total
Exercise/Conversion
Clovis Oncology, Inc.
Stock Option (right to buy)
2019-01-03−6,896→ 0 total
Exercise/Conversion
Clovis Oncology, Inc.
Stock Option (right to buy)
2019-01-03−25,862→ 0 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2019-01-03$0.29/sh+25,862→ 40,376 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2018-10-11+14,770→ 14,770 total
Sale
Clovis Oncology, Inc.
Common Stock
2018-04-09$60.02/sh−4,500→ 7,618 total
Sale
Clovis Oncology, Inc.
Common Stock
2018-03-08$61.47/sh−4,500→ 12,118 total
Sale
Clovis Oncology, Inc.
Common Stock
2018-02-22$60.00/sh−4,500→ 16,618 total
Sale
Clovis Oncology, Inc.
Common Stock
2017-12-08$60.00/sh−4,500→ 25,618 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2017-06-08+10,000→ 10,000 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2016-06-09+10,000→ 10,000 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2015-06-11+10,000→ 10,000 total
Sale
Clovis Oncology, Inc.
Common Stock
2015-05-13$85.00/sh−4,309→ 30,118 total
Sale
Clovis Oncology, Inc.
Common Stock
2013-12-05$55.96/sh−6,000→ 34,427 total
Sale
Clovis Oncology, Inc.
Common Stock
2013-12-04$56.38/sh−3,000→ 40,427 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2013-06-13+12,414→ 12,414 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2012-06-14+12,414→ 12,414 total
Purchase
Clovis Oncology, Inc.
Common Stock
2011-11-21$13.00/sh+13,309→ 43,427 total
Conversion
Clovis Oncology, Inc.
Series A-2 Convertible Preferred Stock
2011-11-21−17,241→ 0 total
Conversion
Clovis Oncology, Inc.
Common Stock
2011-11-21+5,360→ 30,118 total
Conversion
Clovis Oncology, Inc.
Series A-1 Convertible Preferred Stock
2011-11-21−17,241→ 0 total
Conversion
Clovis Oncology, Inc.
Series B Convertible Preferred Stock
2011-11-21−37,319→ 0 total
Conversion
Clovis Oncology, Inc.
Convertible Promissory Notes
2011-11-21→ 0 total
Conversion
Clovis Oncology, Inc.
Common Stock
2011-11-21+5,945→ 5,945 total
Conversion
Clovis Oncology, Inc.
Common Stock
2011-11-21+12,868→ 24,758 total
Award
PHARMION CORP
Stock Option (right to buy)
2007-06-06+7,500→ 7,500 total
Award
PHARMION CORP
Stock Option (right to buy)
2006-06-08+7,500→ 7,500 total
Exercise/Conversion
PHARMION CORP
Common Stock
2005-08-26$2.40/sh+10,625→ 18,750 total
Exercise/Conversion
PHARMION CORP
Stock Option (right to buy)
2005-08-26−5,000→ 0 total
Exercise/Conversion
PHARMION CORP
Stock Option (right to buy)
2005-08-26−10,625→ 0 total
Exercise/Conversion
PHARMION CORP
Common Stock
2005-08-26$2.40/sh+5,000→ 8,125 total
Exercise/Conversion
PHARMION CORP
Common Stock
2005-08-26$1.60/sh+3,125→ 3,125 total
Exercise/Conversion
PHARMION CORP
Stock Option (right to buy)
2005-08-26−3,125→ 0 total
Award
PHARMION CORP
Stock Option (right to buy)
2005-06-01+5,000→ 5,000 total

Companies

Recent Filings

Address

C/O CLOVIS ONCOLOGY, INC. 2525 28TH STREET, SUITE 100

BOULDER, CO, 80301

View on SEC.gov